Clinical experience with a new anticancer agent, carbazilquinone (NSC-134679).
D000328:Adult; D000368:Aged; D000477:Alkylating Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001389:Azirines / Q000009:adverse effects / Q000627:therapeutic use*; D002219:Carbamates / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000188:drug therapy; D011809:Quinones / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D001389:Azirines; D002219:Carbamates; D011809:Quinones